GSK
843 hedge funds and large institutions have $10.4B invested in GSK in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 304 increasing their positions, 267 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
2% more funds holding
Funds holding: 824 → 843 (+19)
5% more capital invested
Capital invested by funds: $9.91B → $10.4B (+$453M)
0.19% more ownership
Funds ownership: 6.79% → 6.98% (+0.19%)
Holders
843
Holding in Top 10
12
Calls
$414M
Puts
$127M
Top Buyers
| 1 | +$160M | |
| 2 | +$76M | |
| 3 | +$54.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$45.1M |
Top Sellers
| 1 | -$130M | |
| 2 | -$104M | |
| 3 | -$46.6M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$46.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$45.3M |